The Aslan Project Inc is located in Washington, DC. The organization was established in 2012. According to its NTEE Classification (Z99) the organization is classified as: Unknown, under the broad grouping of Unknown and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Aslan Project Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, Aslan Project Inc generated $501.1k in total revenue. This represents relatively stable growth, over the past 8 years the organization has increased revenue by an average of 2.1% each year. All expenses for the organization totaled $745.5k during the year ending 12/2023. While expenses have increased by 11.1% per year over the past 8 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
TO PROMOTE EQUITABLE ACCESS TO PEDIATIC CANCER CARE IN LOW -RESOURCE SETTINGS.
Describe the Organization's Program Activity:
Part 3 - Line 4a
THE ASLAN PROJECT IS A WASHINGTON, DC-BASED NONPROFIT ORGANIZATION THAT PROMOTES EQUITABLE ACCESS TO PEDIATRIC CANCER CARE AND TREATMENT IN LOW-RESOURCE SETTINGS. WE COLLABORATE WITH NATIONAL GOVERNMENTS, MAJOR HOSPITALS, ACADEMIC INSTITUTIONS, AND LOCAL NON-GOVERNMENTAL ORGANIZATIONS ("NGOS") TO TRAIN LOCAL HEALTH PROFESSIONALS TO RECOGNIZE, DIAGNOSE, AND TREAT PEDIATRIC CANCERS AND TO PROVIDE FAMILY AND PSYCHOSOCIAL SERVICES THAT ADDRESS THE ROOT CAUSES OF TREATMENT ABANDONMENT.CONTINUES ON SCHEDULE OSINCE 2012, WE HAVE SPEARHEADED THE DEVELOPMENT OF A COMPREHENSIVE PEDIATRIC CANCER HEALTH SYSTEM IN ETHIOPIA. AT THE TIME, THE COUNTRY HAD NO DEDICATED UNIT TO TREAT CHILDREN WITH CANCER, NO PHYSICIANS FORMALLY TRAINING IN PEDIATRIC HEMATOLOGY-ONCOLOGY ("PHO"), NO PEDIATRIC ONCOLOGY NURSES OR ONCOLOGY PHARMACISTS, AND NEGLIGIBLE SURVIVAL RATES.TO ADDRESS THIS CRITICAL NEED, WE PILOTED OUR FIRST PROGRAM AT TIKUR ANBESSA SPECIALIZED HOSPITAL (TASH) IN ADDIS ABABA. OVER THE NEXT SEVERAL YEARS, THE PROGRAM ACHIEVED SIGNIFICANT MILESTONES, INCLUDING THE FIRST DEDICATED PEDIATRIC CANCER UNIT IN ETHIOPIA'S HISTORY; ETHIOPIA'S FIRST PHO FELLOWSHIP PROGRAM; EXPERT TRAINING IN PEDIATRIC ONCOLOGY NURSING AND ONCOLOGY PHARMACY; AND PARTNERSHIPS WITH A LOCAL NGO, TAPCCO, TO PROVIDE FREE HOUSING, COUNSELING, TRANSPORTATION, AND OTHER SUPPORTS SO THAT PEDIATRIC CANCER PATIENTS ARE ENABLED TO COMPLETE THEIR REGIMENS AND THEY AND THEIR FAMILIES CAN THRIVE DURING THEIR TREATMENT JOURNEYS.IN 2015, WE EXPORTED THIS MODEL SUCCESSFULLY TO JIMMA UNIVERSITY MEDICAL CENTER (JUMC) INSOUTHWESTERN ETHIOPIA, SPONSORING AN INAUGURAL WORKSHOP IN COLLABORATION WITH THE FEDERAL MINISTRY OF HEALTH (FMOH), THE WORLD HEALTH ORGANIZATION (WHO), AND THE INTERNATIONAL SOCIETY OF PAEDIATRIC ONCOLOGY (SIOP).IN 2019, WE SIGNED AN AGREEMENT WITH THE FMOH TO LAUNCH NATIONAL TRAININGS IN PHO AND PEDIATRIC ONCOLOGY NURSING AND TO INTRODUCE INITIATIVES TO IMPROVE STANDARDS OF CARE THROUGHOUT THE COUNTRY. IN THE FOLLOWING TWO YEARS, WE INSTITUTED A NEW PHO FELLOWSHIP PROGRAM AT TASH, OFFERED OUR ETHIOPIAN PARTNERS SIGNIFICANT EXPOSURES TO INTERNATIONAL CONFERENCES AND NETWORKS, AND INTRODUCED INTERNATIONAL COLLABORATORS TO AMPLIFY OUR FACULTY'S AREAS OF EXPERTISE AND BANDWIDTH. WE ALSO ADDED THREE NEW PEDIATRIC CANCER PROGRAMS TO OUR NATIONAL NETWORK: AT GONDAR UNIVERSITY SPECIALIZED HOSPITAL (GUSH) IN NORTHERN ETHIOPIA AND ST. PAUL MILLENNIUM MEDICAL COLLEGE HOSPITAL (SPMMCH) IN ADDIS ABABA, AND AYDER COMPREHENSIVE SPECIALIZED HOSPITAL (ACSH) IN MEKELLE.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Dr Meskerem Asresahegn MD Director | Trustee | 2 | $0 |
Mary Grace Fisher Director | Trustee | 2 | $0 |
Dr Tenagne Haile-Mariam MD Director | Trustee | 2 | $0 |
Daphne Himelfarb Director | Trustee | 2 | $0 |
Stuart Himelfarb Director | Trustee | 2 | $0 |
Craig Kline Director | Trustee | 2 | $0 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $24,754 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $465,281 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $490,035 |
Total Program Service Revenue | $0 |
Investment income | $21,684 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $0 |
Net Income from Fundraising Events | -$10,621 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $501,098 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $0 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $347,960 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $178,080 |
Compensation of current officers, directors, key employees. | $12,466 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $0 |
Pension plan accruals and contributions | $0 |
Other employee benefits | $0 |
Payroll taxes | $13,142 |
Fees for services: Management | $0 |
Fees for services: Legal | $0 |
Fees for services: Accounting | $0 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $41,628 |
Advertising and promotion | $0 |
Office expenses | $0 |
Information technology | $0 |
Royalties | $0 |
Occupancy | $0 |
Travel | $110,152 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $0 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $0 |
Insurance | $0 |
All other expenses | $6,446 |
Total functional expenses | $745,502 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $394,532 |
Savings and temporary cash investments | $379,314 |
Pledges and grants receivable | $0 |
Accounts receivable, net | $338,339 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $0 |
Net Land, buildings, and equipment | $0 |
Investments—publicly traded securities | $0 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $1,112,185 |
Accounts payable and accrued expenses | $0 |
Grants payable | $0 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $11,682 |
Total liabilities | $11,682 |
Net assets without donor restrictions | $1,100,503 |
Net assets with donor restrictions | $0 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $1,112,185 |